Investments
Clinical Candidates
Six GHIT development partnerships have conducted successful late-stage projects in Africa and South America. As a result, and numerous promising global health innovations are now firmly within reach.
-
PZQSchistosomiasis / Pediatric DrugDevelopment Stage: Phase Ⅲ
Country: Côte d'Ivoire, Kenya, Zimbabwe
https://www.ghitfund.org/investment/portfoliodetail/detail/103/en
-
DAR-901Tuberculosis / VaccineDevelopment Stage: Phase IIb
Country: Tanzania
https://www.ghitfund.org/investment/portfoliodetail/detail/70/en
-
BK-SE36/CpGMalaria / VaccineDevelopment Stage: Phase Ib
Country: Burkina Faso
https://www.ghitfund.org/investment/portfoliodetail/detail/99/en
-
SJ733Malaria / DrugDevelopment Stage: Phase IIa
Country: Peru
https://www.ghitfund.org/investment/portfoliodetail/detail/106/en
-
TB-LAMTuberculosis / DiagnosticDevelopment Stage: Product validation
Country: South Africa
https://www.ghitfund.org/investment/portfoliodetail/detail/126/en
-
E1224Mycetoma / DrugDevelopment Stage: Phase IIb
Country: Sudan
https://www.ghitfund.org/investment/portfoliodetail/detail/114/en